4519 — Chugai Pharmaceutical Share News
0.000.00%
Last trade - 00:00Notice On Judgment Of Second Instance On Patent Infringement Lawsuit Concerning Edirol Capsules
Table: Chugai Pharm -9-MTH group results (IFRS)
Nikkei inches lower while traders wait on Fed
Table: Chugai Pharm -6-MTH group results (IFRS)
Table: Chugai Pharm -Q1 group results (IFRS)
Halozyme gains on licensing deal with Japan's Chugai for drug delivery system
Brief: Halozyme Therapeutics, Chugai Pharmaceutical Enter Global Collaboration And License Agreement For Enhanze Technology
Brief: Halozyme Therapeutics Says Chugai Will Make An Upfront Payment Of $25 Million To Halozyme
AstraZeneca pays $775 mln to settle drug dispute with Japan's Chugai (updated)
AstraZeneca to pay $775 mln to settle ALS drug dispute
Table: Chugai Pharm -2021 group results (IFRS)
Table: Chugai Pharm -2021 group results (IFRS)
Japan health ministry panel approves expanded use of Chugai's COVID-19 antibody treatment - media
Nikkei slips on soft earnings, U.S. tech worries
Table: Chugai Pharm -9-MTH group results (IFRS)
Japan's Chugai files to expand use of COVID-19 antibody drug
Nikkei snaps 4-day losing streak, but Delta worries persist
Japanese shares bounce back as defensive stocks gain
Table: Chugai Pharm -6-MTH group results (IFRS)